Empowering Precision Medicine: The "Magic Scissors" and "Master Strokes" of Antibody Engineering-Antibody Detection Service Topic-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Empowering Precision Medicine: The "Magic Scissors" and "Master Strokes" of Antibody Engineering

Natural antibodies are far from perfect. For various reasons, they may fail to exert their intended effects, or they may even be mistaken for "enemies" and cleared by our own immune system. Expressing an antibody is only the first step; it is usually engineered and further modified according to the intended application to achieve its maximum utility.

Antibody Engineering

By working at the DNA level, we can fundamentally alter the "properties" of an antibody.

1. Humanized and Fully Human Antibodies

Early therapeutic antibodies were mostly derived from mice (murine antibodies). However, once introduced into the human body, they are recognized as "foreign" by the human immune system, triggering immune responses that lead to rapid antibody clearance, allergic reactions, and greatly compromised efficacy. Today, humanized antibodies can be generated by grafting the complementarity-determining regions (CDRs) of murine antibodies onto a human antibody framework. Going one step further, phage display or transgenic mouse technologies allow the direct generation of fully human antibodies. Such antibodies elicit virtually no immune rejection, greatly improving drug safety and long-term therapeutic efficacy.

2. Antibody Fragments and Miniaturization

A full-length IgG antibody is structurally bulky, which results in poor tissue penetration. Expressing individual functional fragments of the antibody—such as Fab fragments, single-chain variable fragments (scFv), or nanobodies—greatly improves tissue penetration while exhibiting faster clearance, offering clear advantages in tumor imaging and radioimmunotherapy.

3. Antibody–Drug Conjugates (ADCs)

ADCs represent a perfect combination of engineering and chemical modification. An ADC drug consists of three components: antibody + linker + cytotoxic payload. The antibody is responsible for precisely recognizing and binding a specific antigen; the entire ADC is then internalized into the cell, thereby killing tumor cells with precision.

Antibody Modification

Antibody modification refers to chemical modification performed at the protein level.

PEGylation

PEG is the abbreviation for polyethylene glycol, a non-toxic, non-immunogenic, and highly hydrophilic polymer. The primary purpose of PEGylation is to extend the half-life: a hydrophilic protective shield formed on the antibody surface slows its clearance from the bloodstream, improves solubility and formulation stability, and can mask epitopes on the antibody surface that might otherwise be recognized by the immune system, further reducing immunogenicity. PEGylation is widely used in the development of long-acting drugs; many protein and peptide drugs have achieved once-weekly or even once-biweekly dosing through PEGylation.

Fluorescent and Quencher Labeling

Commonly used labels include:

● FITC: Emits green fluorescence. As one of the "veteran" fluorophores in flow cytometry, it is inexpensive and widely used.

● Cy5/Cy7: Emit far-red/near-infrared fluorescence. Biological tissues exhibit weak autofluorescence and strong light penetration in this spectral range, so Cy5/Cy7-labeled antibodies are particularly suitable for in vivo imaging and deep-tissue imaging, enabling non-invasive tracking of tumors, inflammation, and other lesions.

● Quenchers: Such as BHQ and Dabcyl. They do not fluoresce themselves, but can effectively absorb or transfer the energy emitted by fluorescent groups at specific wavelengths, rendering the signal undetectable.

Flow cytometry uses multiple antibodies labeled with different fluorophores simultaneously, enabling rapid, multiparametric quantitative analysis of mixed cell populations (such as blood). Cy5- or Cy7-labeled antibodies injected into animal models allow real-time in vivo tracking of antibody behavior. Fluorescent dyes and quenchers are commonly used to prepare probes and biosensors.

Tek Biotech (Tianjin) Co., Ltd. has established a comprehensive targeted antibody drug discovery platform based on phage display and yeast display technologies, providing scientists worldwide with high-quality development services for monoclonal antibodies of various formats, including scFv, VHH, and Fab. We can also develop antibodies with various functional structural characteristics (including but not limited to neutralizing antibodies, conformation-specific antibodies, and cross-reactive antibodies). In addition, Tek Biotechnology offers a full suite of downstream services, including antibody expression and validation, antibody humanization design and validation, antibody affinity maturation, and CAR-T candidate sequence design, meeting the diverse needs of clients for therapeutic antibody development.

Previous:Humanization calculation method and structural feature analysis of nanobodies！ Next:Magnetic Beads: How Do They Make SELEX Technology Fast, Precise, and Reliable?